Literature DB >> 11672818

Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection.

S J Hadziyannis1, D Vassilopoulos.   

Abstract

Hepatitis B e antigen (HBeAg) negative chronic hepatitis B represents currently the predominant form of chronic hepatitis due to the hepatitis B virus (HBV) in several parts of the world. In this review, recent data regarding the process of HBeAg negative HBV strain selection during the course of chronic HBV infection are presented and the potential virus and/or host-mediated mechanisms that lead to chronic liver necroinflammation, i.e. chronic hepatitis are outlined.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11672818     DOI： 10.1016/s0166-3542(01)00173-5

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


  11 in total

1.  Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections.

Authors:  Ruy M Ribeiro; Georgios Germanidis; Kimberly A Powers; Bertrand Pellegrin; Paul Nikolaidis; Alan S Perelson; Jean-Michel Pawlotsky
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

2.  Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.

Authors:  Yuan Wang; Lei Cui; Guifang Yang; Jianbo Zhan; Liang Guo; Yu Chen; Chengpeng Fan; Dan Liu; Deyin Guo
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

3.  Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance.

Authors:  He-Jun Yuan; Man-Fung Yuen; Danny Ka-Ho Wong; Siu-Man Sum; Joke Doutreloigne; Erwin Sablon; Ching-Lung Lai
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial.

Authors:  Hanmin Li; Zhihua Ye; Xiang Gao; Lisheng Zhang; Xin Yao; Jianxun Gu; Dingbo Lu; Ming Wan; Lin Xiao; Wangxi Cai; Xuesheng Yan; Binbin Zhao; Yu Wu; Jinrong Zhang
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 5.  Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions.

Authors:  Hong-Zhi Xu; Yun-Peng Liu; Bayasi Guleng; Jian-Lin Ren
Journal:  Gastrointest Tumors       Date:  2014-07-18

Review 6.  HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.

Authors:  Alexandra Alexopoulou; Peter Karayiannis
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

7.  Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia.

Authors:  Henock Ambachew; Meijuan Zheng; Faustina Pappoe; Jilong Shen; Yuanhong Xu
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

8.  Different Mechanisms May Exist for HBsAg Synthesis and Secretion During Various Phases of Chronic Hepatitis B Virus Infection.

Authors:  Yunsong Li; Qun Cai; Qinxiu Xie; Yafei Zhang; Xiangling Meng; Zhenhua Zhang
Journal:  Med Sci Monit       Date:  2017-03-21

9.   Evaluation of serum HBV viral load, transaminases and histological features in chronic HBeAg-negative hepatitis B patients.

Authors:  Abbas Esmaeelzadeh; Hassan Saadatnia; Bahram Memar; Elham Mokhtari Amirmajdi; Azita Ganji; Ladan Goshayeshi; Zahra Meshkat; Alireza Pasdar; Hassan Vosoughinia; Mohammadreza Farzanehfar; Shahrzad Tehranian; Kamran Ghaffarzadehgan; Farnood Rajabzadeh; Mitra Ahadi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

Review 10.  The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics.

Authors:  Anna Kramvis
Journal:  Rev Med Virol       Date:  2016-05-03       Impact factor: 6.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.